ClinVar Miner

Submissions for variant NM_001083962.2(TCF4):c.514_517del (p.Lys172fs)

dbSNP: rs398123561
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 9
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000255366 SCV000111340 pathogenic not provided 2016-06-28 criteria provided, single submitter clinical testing
Diagnostic Laboratory, Strasbourg University Hospital RCV000224701 SCV000281728 pathogenic Intellectual disability 2014-07-25 criteria provided, single submitter clinical testing
GeneDx RCV000255366 SCV000322052 pathogenic not provided 2022-08-28 criteria provided, single submitter clinical testing Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 22045651, 25167861, 31105003, 32959227, 26147798, 28569743, 25780760, 22722829, 31785789, 22460224)
Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU München RCV000995665 SCV001149961 pathogenic Pitt-Hopkins syndrome 2019-05-15 criteria provided, single submitter clinical testing
Clinical Genetics and Genomics, Karolinska University Hospital RCV000255366 SCV001449866 pathogenic not provided 2016-06-30 criteria provided, single submitter clinical testing
Laboratory of Molecular Genetics (Pr. Bezieau's lab), CHU de Nantes RCV001374933 SCV001572221 pathogenic Neurodevelopmental disorder 2020-02-21 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV000255366 SCV001746548 pathogenic not provided 2021-06-01 criteria provided, single submitter clinical testing
Centogene AG - the Rare Disease Company RCV000995665 SCV002059376 pathogenic Pitt-Hopkins syndrome 2019-02-11 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV000995665 SCV004297853 pathogenic Pitt-Hopkins syndrome 2023-07-12 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Lys172Phefs*61) in the TCF4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TCF4 are known to be pathogenic (PMID: 18728071, 22045651). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 93545). This premature translational stop signal has been observed in individual(s) with Pitt-Hopkins syndrome (PMID: 22045651). This variant is not present in population databases (gnomAD no frequency).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.